SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-15-319398
Filing Date
2015-09-14
Accepted
2015-09-14 15:43:47
Documents
11
Period of Report
2015-06-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q d39374d10q.htm 10-Q 577940
2 EX-31.1 d39374dex311.htm EX-31.1 7950
3 EX-31.2 d39374dex312.htm EX-31.2 7742
4 EX-32.1 d39374dex321.htm EX-32.1 3552
5 EX-32.2 d39374dex322.htm EX-32.2 3517
  Complete submission text file 0001193125-15-319398.txt   4651818

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT vtvt-20150630.xml EX-101.INS 795311
7 XBRL TAXONOMY EXTENSION SCHEMA vtvt-20150630.xsd EX-101.SCH 59315
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE vtvt-20150630_cal.xml EX-101.CAL 58849
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE vtvt-20150630_def.xml EX-101.DEF 330546
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE vtvt-20150630_lab.xml EX-101.LAB 422672
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE vtvt-20150630_pre.xml EX-101.PRE 399118
Mailing Address 4170 MENDENHALL OAKS PKWY HIGH POINT NC 27265
Business Address 4170 MENDENHALL OAKS PKWY HIGH POINT NC 27265 336-841-0300
vTv Therapeutics Inc. (Filer) CIK: 0001641489 (see all company filings)

IRS No.: 473916571 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37524 | Film No.: 151105484
SIC: 2834 Pharmaceutical Preparations